ArticleFrontiers in oncology2026

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report.

Chelsey M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.